Northern Trust Corp Reata Pharmaceuticals Inc Transaction History

Northern Trust Corp

$600 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $405,606 - $539,494	5,120 Added 1.81%	287,968 $29.4 Million
Q1 2023 May 15, 2023	BUY	$30.85 - $93.17 $338,023 - $1.02 Million	10,957 Added 4.03%	282,848 $25.7 Million
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $298,980 - $568,400	13,498 Added 5.22%	271,891 $10.3 Million
Q3 2022 Nov 14, 2022	SELL	$19.41 - $36.49 $48,757 - $91,662	-2,512 Reduced 0.96%	258,393 $6.49 Million
Q2 2022 Aug 12, 2022	SELL	$20.71 - $36.5 $158,431 - $279,225	-7,650 Reduced 2.85%	260,905 $7.93 Million
Q1 2022 May 13, 2022	SELL	$24.12 - $39.6 $183,915 - $301,950	-7,625 Reduced 2.76%	268,555 $8.8 Million
Q4 2021 Feb 08, 2022	SELL	$25.61 - $110.96 $3,790 - $16,422	-148 Reduced 0.05%	276,180 $7.28 Million
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $1.28 Million - $1.83 Million	-12,768 Reduced 4.42%	276,328 $27.8 Million
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $12.3 Million - $23.8 Million	157,277 Added 119.31%	289,096 $40.9 Million
Q1 2021 May 12, 2021	BUY	$94.25 - $132.81 $625,725 - $881,725	6,639 Added 5.3%	131,819 $13.1 Million
Q4 2020 Feb 11, 2021	BUY	$102.03 - $184.62 $481,377 - $871,037	4,718 Added 3.92%	125,180 $15.5 Million
Q3 2020 Nov 16, 2020	SELL	$93.53 - $163.34 $880,304 - $1.54 Million	-9,412 Reduced 7.25%	120,462 $11.7 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $19.8 Million - $27.7 Million	-157,000 Reduced 54.73%	129,874 $20.3 Million
Q1 2020 May 14, 2020	BUY	$124.16 - $247.74 $810,516 - $1.62 Million	6,528 Added 2.33%	286,874 $41.4 Million
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $1.43 Million - $4.17 Million	19,143 Added 7.33%	280,346 $57.3 Million
Q3 2019 Nov 13, 2019	BUY	$71.26 - $95.75 $1.88 Million - $2.52 Million	26,351 Added 11.22%	261,203 $21 Million
Q2 2019 Aug 13, 2019	BUY	$77.72 - $94.35 $177,978 - $216,061	2,290 Added 0.98%	234,852 $22.2 Million
Q1 2019 May 13, 2019	BUY	$51.9 - $101.79 $201,372 - $394,945	3,880 Added 1.7%	232,562 $19.9 Million
Q4 2018 Feb 12, 2019	SELL	$48.76 - $76.44 $185,726 - $291,159	-3,809 Reduced 1.64%	228,682 $12.8 Million
Q3 2018 Nov 14, 2018	BUY	$35.64 - $92.06 $1.73 Million - $4.47 Million	48,561 Added 26.4%	232,491 $19 Million
Q2 2018 Sep 18, 2018	SELL	$19.94 - $40.96 $33,678 - $69,181	-1,689 Reduced 0.91%	183,930 $6.43 Million
Q2 2018 Aug 14, 2018	BUY	$19.94 - $40.96 $1.11 Million - $2.28 Million	55,635 Added 42.8%	185,619 $6.49 Million
Q1 2018 May 09, 2018	BUY	$20.0 - $30.19 $34,700 - $52,379	1,735 Added 1.35%	129,984 $2.67 Million
Q4 2017 Feb 14, 2018	SELL	$22.39 - $33.27 $80,648 - $119,838	-3,602 Reduced 2.73%	128,249 $3.63 Million
Q3 2017 Nov 13, 2017	BUY	$26.29 - $31.88 $3.47 Million - $4.2 Million	131,851	131,851 $4.1 Million

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account